Materiały źródłowe

• #1 Thrombophilia: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/21797-thrombophilia

  Thrombophilia treatment for acquired or inherited types of the condition may include compression stockings for your legs or medicine to prevent or break up a blood clot. Some people may need surgery to remove a blood clot. […] Providers order medications, such as: Blood thinners (anticoagulants) like heparin, warfarin (Coumadin or Jantoven) or newer blood thinners like rivaroxaban or apixaban. […] Although you cant cure the kind of thrombophilia that you inherit, you can treat it. […] Its important to know that blood thinners dont dissolve blood clots. They stabilize the blood clots so they dont move or get bigger, and allow your bodys natural resources to absorb the clot over time. […] If youre at a high risk of blood clots, your provider may give you: Heparin after surgery if youre at risk for a venous thromboembolism (VTE). […] Nearly 90% of people who have thrombophilia never get a blood clot, but some people get one or more serious clots. […] You may need to take blood thinners if your risk of forming more blood clots is high.

• #2 Thrombophilia

  https://www.nhs.uk/conditions/thrombophilia/

  There is currently no cure for thrombophilia that’s caused by altered genes you inherit from your parents (inherited thrombophilia). […] Thrombophilia that starts later in life (acquired thrombophilia) can sometimes get better if the underlying cause is treated. […] If you need treatment, you’ll usually be offered anticoagulant medicine. It works by making your blood less sticky so it’s less likely to clot.

• #3 Thrombophilia: Causes, Symptoms, and Treatment

  https://patient.info/allergies-blood-immune/blood-clotting-tests/thrombophilia

  What is the treatment for thrombophilia? […] The first step is for you and your doctor to consider how much risk there is of you developing a blood clot. […] Possible treatments for thrombophilia are: […] Low-dose aspirin inhibits the action of platelets, so can help to prevent blood clots. […] Anticoagulation is often called 'thinning’ of the blood. […] Anticoagulant medication is commonly used to treat a venous thrombosis (such as a DVT) or a pulmonary embolism. […] In thrombophilia, anticoagulant medication may be advised if: […] You have had a blood clot, to prevent another one. […] You have not had a blood clot but have a high risk of developing one. […] You have a temporary situation that puts you at high risk of a blood clot. […] Warfarin is the usual anticoagulant.

• #4 Thrombophilia: Causes, Symptoms, and Treatment

  https://patient.info/allergies-blood-immune/blood-clotting-tests/thrombophilia

  The aim is to get the dose of warfarin just right so the blood will not clot easily. […] An INR of 2.5 is usually the aim if you take warfarin to prevent a blood clot in thrombophilia or to treat a DVT or pulmonary embolism. […] Heparin is an injectable anticoagulant. […] If you are pregnant or planning a pregnancy, discuss this with your doctor, and tell your midwife and doctor specialising in pregnancy and childbirth (obstetrician) about the thrombophilia. […] Treatment for thrombophilia may be different in pregnancy because: […] Some women with certain types of thrombophilia are advised to take low-dose aspirin while pregnant, to help prevent miscarriage or pregnancy problems. […] The pregnancy itself increases the risk of a venous thrombosis – this applies to the whole pregnancy and especially to the six weeks after childbirth.

• #5 Thrombophilia (Hypercoagulable States) – Bleeding Disorders – Hematology – Diseases – McMaster Textbook of Internal Medicine

  https://empendium.com/mcmtextbook/chapter/B31.II.15.22.

  1. Treatment modalities and outcomes of acute VTE in patients with thrombophilia are the same as in patients with other forms of venous thrombosis. In patients with severe deficiency of natural anticoagulants, additional options (substitution) should be considered. The presence of a thrombophilia may influence the duration of treatment. […] 2. In patients who would otherwise be discontinuing anticoagulants, lifelong secondary antithrombotic prevention with a VKA or DOAC could be considered after the first episode of VTE in patients with AT deficiency, homozygotes for factor V Leiden, or patients with the 20210A variant of the prothrombin gene, as well as patients with coexisting heterozygosity for these conditions, or in patients with antiphospholipid syndrome with an unprovoked VTE event. After the first episode of unprovoked thrombosis in patients with types of thrombilia other than those mentioned above, anticoagulant treatment should be continued for 3 months. Consideration for extended-duration therapy in such patients (particularly men) is reasonable if the risk of bleeding is low to moderate. […] 3. Patients with suspected TTS should have diagnostic testing performed before treatment with high-dose IV immunoglobulins and nonheparin anticoagulants is initiated, but likely without waiting for results.

• #6 Thrombophilia: Inherited, Symptoms, Screen Test, Treatment, Cause

  https://www.healthline.com/health/thrombophilia

  You may not need treatment at all unless you develop a blood clot or are at high risk of developing one. Some factors that can influence treatment decisions are: […] Medications may include anticoagulants such as warfarin or heparin. Warfarin (Coumadin or Jantoven) is an oral drug, but it takes a few days to start working. If you have a clot that needs immediate treatment, heparin is a fast-acting injectable drug that can be used with the warfarin. […] If you have thrombophilia, or if you’re taking anticlotting medications, be sure to inform all healthcare professionals before having medical procedures. […] In some cases, your doctor may recommend long-term use of blood thinners, which will require periodic blood testing. […] Thrombophilia can be successfully managed.

• #7 Blood Clotting Disorders: Types, Signs and Treatment

  https://my.clevelandclinic.org/health/diseases/16788-blood-clotting-disorders-hypercoagulable-states

  A blood clotting disorder makes your blood form clots too easily. This is also called a hypercoagulable state or thrombophilia. […] In most cases, you only need blood clotting disorder treatment when a blood clot develops in a vein or artery. Anticoagulants decrease your blood’s ability to clot and prevent additional clots from forming. […] Anticoagulant medications include: Aspirin, Warfarin (Coumadin or Jantoven), Heparin, Low-molecular weight heparin, Fondaparinux, Direct oral anticoagulants (tablets) such as rivaroxaban, apixaban or dabigatran. […] Your healthcare provider will talk to you about the benefits and risks of these medications. This information, along with your diagnosis, will help determine the type of anticoagulant medication you will take, how long you will need to take it, and the type of follow-up monitoring you need.

• #8 What Is Thrombophilia?

  https://www.webmd.com/dvt/thrombophilia-overview

  There is no treatment for thrombophilia until you get a blood clot. What happens then depends on where the clot is, its size, and other things. […] If you have the antiphospholipid antibody syndrome form of thrombophilia, you may need long-term treatment with blood thinners. […] If you’re a woman, you may need to avoid certain forms of hormonal birth control that have estrogen. You could take progestin-only pills instead. Your doctor also may recommend staying away from hormone replacement therapy for menopause symptoms. […] If you have thrombophilia, you can lower your chances of having unwanted blood clots with lifestyle changes, including: Exercise, Keeping a healthy weight, Limiting salt, saturated fats, and cholesterol, Avoiding long periods of not moving.

• #9 Thrombophilia | nidirect

  https://www.nidirect.gov.uk/conditions/thrombophilia

  Many people with thrombophilia won’t need treatment. You’ll only need treatment if you develop a blood clot or you’re at risk of developing a clot. […] If you have been diagnosed with thrombophilia, the healthcare professional managing your care will discuss with you the most appropriate treatment options.

• #10 Thrombophilia: Causes, Symptoms, and Treatment

  https://patient.info/allergies-blood-immune/blood-clotting-tests/thrombophilia

  Certain situations can temporarily put you at high risk of having a blood clot, and in these situations you may be advised to take extra treatment for a while. […] If you are having any medical treatment or surgery, tell your doctor/nurse/pharmacist about the thrombophilia. […] It is therefore important to be aware of the symptoms and seek treatment immediately if you suspect any kind of blood clot. […] Many forms of thrombophilia are mild, so that the outlook (prognosis) for many people with thrombophilia means that they have no problems from their condition. […] Treatment with anticoagulant medication has to be carefully assessed, as its use also has certain risks, such as bleeding.

• #11 Thrombophilia: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/21797-thrombophilia

  Thrombophilia treatment for acquired or inherited types of the condition may include compression stockings for your legs or medicine to prevent or break up a blood clot. Some people may need surgery to remove a blood clot. […] Providers order medications, such as: Blood thinners (anticoagulants) like heparin, warfarin (Coumadin or Jantoven) or newer blood thinners like rivaroxaban or apixaban. […] Although you cant cure the kind of thrombophilia that you inherit, you can treat it. […] Its important to know that blood thinners dont dissolve blood clots. They stabilize the blood clots so they dont move or get bigger, and allow your bodys natural resources to absorb the clot over time. […] If youre at a high risk of blood clots, your provider may give you: Heparin after surgery if youre at risk for a venous thromboembolism (VTE). […] Nearly 90% of people who have thrombophilia never get a blood clot, but some people get one or more serious clots. […] You may need to take blood thinners if your risk of forming more blood clots is high.

• #12 Thrombophilia | Clotting Disorders | UC Davis Hemostasis and Thrombosis Center

  https://health.ucdavis.edu/hemophilia/clotting-disorders/thrombophilia.html

  Thrombophilia is a condition in which there’s an imbalance in naturally occurring blood-clotting proteins, or clotting factors. This can put people at risk of developing blood clots. […] Treatment may not be needed at all unless a blood clot develops, or if an individual is at high risk of developing one. […] Medications may include anticoagulants such as warfarin or heparin. Warfarin (Coumadin or Jantoven) is an oral drug, but it takes a few days to start working. In the case of a clot that needs immediate treatment, heparin is a fast-acting injectable drug that can be used with the warfarin. […] Regular blood testing needs to be done to make sure that the right amount of warfarin is being taken. Blood tests include the prothrombin time test and International Normalized Ratio (INR).

• #13 Blood Clotting Disorders: Types, Signs and Treatment

  https://my.clevelandclinic.org/health/diseases/16788-blood-clotting-disorders-hypercoagulable-states

  A blood clotting disorder makes your blood form clots too easily. This is also called a hypercoagulable state or thrombophilia. […] In most cases, you only need blood clotting disorder treatment when a blood clot develops in a vein or artery. Anticoagulants decrease your blood’s ability to clot and prevent additional clots from forming. […] Anticoagulant medications include: Aspirin, Warfarin (Coumadin or Jantoven), Heparin, Low-molecular weight heparin, Fondaparinux, Direct oral anticoagulants (tablets) such as rivaroxaban, apixaban or dabigatran. […] Your healthcare provider will talk to you about the benefits and risks of these medications. This information, along with your diagnosis, will help determine the type of anticoagulant medication you will take, how long you will need to take it, and the type of follow-up monitoring you need.

• #14 Primary thrombophilia XV: antithrombotic treatment of sticky platelet syndrome worldwide – García-Navarrete – Annals of Blood

  https://aob.amegroups.org/article/view/5039/html

  Sticky platelet syndrome (SPS) is a common but under-recognized cause of thrombosis. Treatment with antiplatelet drugs results in a low re-thrombosis rate. […] Most patients with SPS are treated with antiplatelet drugs worldwide, the re-thrombosis rate is very low. Physicians worldwide are aware of the fact that the best treatment for persons with the SPS is the use of antiplatelet drugs. […] Treatment of SPS relies on diminishing the inherent platelet hyperaggregability by means of anti-platelet drugs; in most cases, aspirin appears adequate but there are situations in which other anti-platelet drugs must be employed. […] By using antiplatelet drugs, mainly aspirin, the platelet hyperreactivity of patients can be reverted and that this translates into a low re-thrombosis rate. […] The re-thrombosis rate for patients given antiplatelet drugs was 5/332 (1.5%) and only 3 patients died.

• #15 Primary thrombophilia XV: antithrombotic treatment of sticky platelet syndrome worldwide – García-Navarrete – Annals of Blood

  https://aob.amegroups.org/article/view/5039/html

  The re-thrombosis rate that we found in our previous prospective study (3.6%), contrasts with that observed in the whole group of patients which we are presenting here (1.5%); this may stem from the fact that the data collection period in our group is substantially longer. […] For patients with history of thrombosis and the SPS phenotype, in a prospective study, we found that the platelet hyperaggregability can be reverted by means of aspirin in most cases (75%), whereas other/additional antiplatelet drugs were needed in the remaining 25%. […] In summary, we have found that physicians worldwide are aware of the fact that the best treatment for persons with the SPS is the use of antiplatelet drugs. The rethrombosis rate is very low.

• #16 Thrombophilia: Causes, Symptoms, and Treatment

  https://patient.info/allergies-blood-immune/blood-clotting-tests/thrombophilia

  The aim is to get the dose of warfarin just right so the blood will not clot easily. […] An INR of 2.5 is usually the aim if you take warfarin to prevent a blood clot in thrombophilia or to treat a DVT or pulmonary embolism. […] Heparin is an injectable anticoagulant. […] If you are pregnant or planning a pregnancy, discuss this with your doctor, and tell your midwife and doctor specialising in pregnancy and childbirth (obstetrician) about the thrombophilia. […] Treatment for thrombophilia may be different in pregnancy because: […] Some women with certain types of thrombophilia are advised to take low-dose aspirin while pregnant, to help prevent miscarriage or pregnancy problems. […] The pregnancy itself increases the risk of a venous thrombosis – this applies to the whole pregnancy and especially to the six weeks after childbirth.

• #17 Blood Clotting Disorders: Types, Signs and Treatment

  https://my.clevelandclinic.org/health/diseases/16788-blood-clotting-disorders-hypercoagulable-states

  A blood clotting disorder makes your blood form clots too easily. This is also called a hypercoagulable state or thrombophilia. […] In most cases, you only need blood clotting disorder treatment when a blood clot develops in a vein or artery. Anticoagulants decrease your blood’s ability to clot and prevent additional clots from forming. […] Anticoagulant medications include: Aspirin, Warfarin (Coumadin or Jantoven), Heparin, Low-molecular weight heparin, Fondaparinux, Direct oral anticoagulants (tablets) such as rivaroxaban, apixaban or dabigatran. […] Your healthcare provider will talk to you about the benefits and risks of these medications. This information, along with your diagnosis, will help determine the type of anticoagulant medication you will take, how long you will need to take it, and the type of follow-up monitoring you need.

• #18 Thrombophilia – Blood Clots

  https://www.stoptheclot.org/about-clots/thrombophilia/thrombophilia/

  People with HAD are often treated by getting extra antithrombin to compensate for the antithrombin that is missing from the body. Treatment is more common in certain high-risk situations such as surgery, pregnancy and childbirth, or when the person already has a blood clot. […] Blood clots are managed with anticoagulants, also known as blood thinners. […] The goal will be to maximize treatment benefits while minimizing adverse effects.

• #19 Inherited and Secondary Thrombophilia: Clinician Update

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3979345/

  Thrombophilia is defined as a predisposition (susceptibility) to thrombosis. […] Most persons with a thrombophilia do not develop thrombosis. Thus, thrombophilia must be considered in the context of other risk factors for incident thrombosis, or predictors of recurrent thrombosis, when estimating the need for primary or secondary prophylaxis, respectively. […] In general, patients with an inherited or acquired thrombophilia and a first-lifetime venous thromboembolism should be managed in standard fashion with intravenous unfractionated heparin, low-molecular-weight heparin (LMWH), fondaparinux, or rivaroxaban. […] Secondary prophylaxis may be recommended after completion of acute treatment for patients at high risk for VTE recurrence and acceptable risk for a bleeding complication. […] Secondary prophylaxis may be recommended for idiopathic, recurrent, or life-threatening venous thromboembolism (e.g., pulmonary embolism, especially in association with persistently reduced cardiopulmonary functional reserve due to chronic cardiopulmonary disease; phlegmasia with threatened venous gangrene; or purpura fulminans), persistent clinical risk factors (e.g., active cancer, chronic neurological disease with leg paresis, or other persistent secondary causes of thrombophilia), a persistent lupus anticoagulant and/or high-titer anticardiolipin or anti-beta2 glycoprotein-1 antibody, antithrombin, protein C or protein S deficiency, increased basal factor VIII activity or hyperhomocysteinemia, combined heterozygous carriers for more than one familial thrombophilia (e.g., heterozygous for the factor V Leiden and prothrombin G20210A mutations, etc.), or homozygous carriers, a persistently increased plasma fibrin D-dimer, and possibly residual vein thrombosis.

• #20 Inherited and Secondary Thrombophilia: Clinician Update

  https://pmc.ncbi.nlm.nih.gov/articles/PMC3979345/

  The risk of recurrence among isolated heterozygous carriers for either the factor V Leiden or prothrombin G20201A mutations is relatively low and insufficient to warrant secondary prophylaxis. […] The risk of venous thromboembolism recurrence decreases with time following the incident event, and the risk of anticoagulant-related bleeding also may vary over time. Consequently, the benefits and risks of secondary prophylaxis must be continually re-evaluated. […] Special coagulation testing for an inherited or acquired thrombophilia showed reduced plasma antithrombin activity and antigen. […] Secondary prophylaxis was recommended after acute treatment was completed. […] Hyperhomocysteinemia is a weak risk factor for incident and recurrent VTE. […] For both of these cases, thrombophilia testing identified treatable and acquired important risk factors for VTE and guided recommendations for secondary prophylaxis.

• #21 Thrombophilia (Hypercoagulable States) – Bleeding Disorders – Hematology – Diseases – McMaster Textbook of Internal Medicine

  https://empendium.com/mcmtextbook/chapter/B31.II.15.22.

  1. Treatment modalities and outcomes of acute VTE in patients with thrombophilia are the same as in patients with other forms of venous thrombosis. In patients with severe deficiency of natural anticoagulants, additional options (substitution) should be considered. The presence of a thrombophilia may influence the duration of treatment. […] 2. In patients who would otherwise be discontinuing anticoagulants, lifelong secondary antithrombotic prevention with a VKA or DOAC could be considered after the first episode of VTE in patients with AT deficiency, homozygotes for factor V Leiden, or patients with the 20210A variant of the prothrombin gene, as well as patients with coexisting heterozygosity for these conditions, or in patients with antiphospholipid syndrome with an unprovoked VTE event. After the first episode of unprovoked thrombosis in patients with types of thrombilia other than those mentioned above, anticoagulant treatment should be continued for 3 months. Consideration for extended-duration therapy in such patients (particularly men) is reasonable if the risk of bleeding is low to moderate. […] 3. Patients with suspected TTS should have diagnostic testing performed before treatment with high-dose IV immunoglobulins and nonheparin anticoagulants is initiated, but likely without waiting for results.

• #22 Recurrent Venous Thromboembolism | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p377.html

  Venous thromboembolism (VTE) recurrence rates are three times higher in patients with chronic or no risk factors compared with those who have transient risk factors after stopping anticoagulation therapy. […] Thrombophilia evaluation should be considered only in selected patients because routine evaluation has not been shown to improve outcomes. […] Patients with VTE should receive three months of anticoagulation therapy. […] There is growing evidence regarding the use of risk assessment models to determine risk of recurrence, but this has not been incorporated into guidelines. […] Do not routinely test for thrombophilia in patients with provoked VTE. Routine testing in patients with unprovoked VTE is discouraged. […] Patients with VTE due to chronic risk factors or with no identifiable risk factors (unprovoked) should continue anticoagulation indefinitely unless they are at high risk of bleeding.

• #23 Thrombophilia: Symptoms and Treatment | Doctor

  https://patient.info/doctor/thrombophilia-pro

  Thrombophilia treatment and management […] The use of short- or long-term anticoagulation should be considered, weighing up the reduction of VTE risk against the risk of serious haemorrhage. This depends on the individual diagnosis and any other medical conditions. Guidelines suggest that, as a general rule: […] All patients with known thrombophilia or previous VTE – consider short-term thromboprophylaxis at times of increased VTE risk. […] Patients with 2 spontaneous VTEs – consider indefinite anticoagulation. […] Patients with recurrent VTEs linked to a provoking factor (eg, surgery, pregnancy, oestrogen use) may not require long-term anticoagulation but do require prophylaxis during any further high-risk situations. […] Asymptomatic family members found to have a thrombophilic genotype – the risk of long-term anticoagulation outweighs the benefits. Consider short-term prophylaxis to cover periods of high VTE risk.

• #24 Thrombophilia (Hypercoagulable States) – Bleeding Disorders – Hematology – Diseases – McMaster Textbook of Internal Medicine

  https://empendium.com/mcmtextbook/chapter/B31.II.15.22.

  1. Treatment modalities and outcomes of acute VTE in patients with thrombophilia are the same as in patients with other forms of venous thrombosis. In patients with severe deficiency of natural anticoagulants, additional options (substitution) should be considered. The presence of a thrombophilia may influence the duration of treatment. […] 2. In patients who would otherwise be discontinuing anticoagulants, lifelong secondary antithrombotic prevention with a VKA or DOAC could be considered after the first episode of VTE in patients with AT deficiency, homozygotes for factor V Leiden, or patients with the 20210A variant of the prothrombin gene, as well as patients with coexisting heterozygosity for these conditions, or in patients with antiphospholipid syndrome with an unprovoked VTE event. After the first episode of unprovoked thrombosis in patients with types of thrombilia other than those mentioned above, anticoagulant treatment should be continued for 3 months. Consideration for extended-duration therapy in such patients (particularly men) is reasonable if the risk of bleeding is low to moderate. […] 3. Patients with suspected TTS should have diagnostic testing performed before treatment with high-dose IV immunoglobulins and nonheparin anticoagulants is initiated, but likely without waiting for results.

• #25 Thrombophilia: Causes, Symptoms, and Treatment

  https://patient.info/allergies-blood-immune/blood-clotting-tests/thrombophilia

  The aim is to get the dose of warfarin just right so the blood will not clot easily. […] An INR of 2.5 is usually the aim if you take warfarin to prevent a blood clot in thrombophilia or to treat a DVT or pulmonary embolism. […] Heparin is an injectable anticoagulant. […] If you are pregnant or planning a pregnancy, discuss this with your doctor, and tell your midwife and doctor specialising in pregnancy and childbirth (obstetrician) about the thrombophilia. […] Treatment for thrombophilia may be different in pregnancy because: […] Some women with certain types of thrombophilia are advised to take low-dose aspirin while pregnant, to help prevent miscarriage or pregnancy problems. […] The pregnancy itself increases the risk of a venous thrombosis – this applies to the whole pregnancy and especially to the six weeks after childbirth.

• #26 Thrombophilia in Pregnancy: Screening and Management – The ObG Project

  https://www.obgproject.com/2018/07/18/acog-guidance-on-thrombophilia-in-pregnancy/

  Pregnancy is a well-known hypercoagulable state and inherited thrombophilias can further increase the risk for maternal venous thromboembolism (VTE). ACOG addresses the different thrombophilias as well as associations with possible adverse pregnancy outcomes. […] Anticoagulation for VTE Prophylaxis. […] Low-risk thrombophilia without personal VTE history. […] High-risk thrombophilia without previous VTE. […] High-risk thrombophilia with one previous episode of VTE or affected first-degree relative (not receiving long-term anticoagulation therapy). […] Thrombophilia with ≥2 VTE episodes (not receiving long-term anticoagulation therapy). […] Thrombophilia with ≥2 VTE episodes (receiving long-term anticoagulation therapy). […] ACOG states “There is insufficient evidence to recommend anticoagulation as an intervention to prevent adverse pregnancy outcomes among women with inherited thrombophilias.” […] LMWH (preferred therapy) and unfractionated heparin do not cross the placenta. […] Avoid oral direct thrombin inhibitors (dabigatran) and anti-Xa inhibitors (rivaroxaban, apixaban). […] Prophylactic, intermediate or adjusted dose LMWH for 6-8 weeks as indicated.

• #27 Thrombophilia in Pregnancy: Screening and Management – The ObG Project

  https://www.obgproject.com/2018/07/18/acog-guidance-on-thrombophilia-in-pregnancy/

  Pregnancy is a well-known hypercoagulable state and inherited thrombophilias can further increase the risk for maternal venous thromboembolism (VTE). ACOG addresses the different thrombophilias as well as associations with possible adverse pregnancy outcomes. […] Anticoagulation for VTE Prophylaxis. […] Low-risk thrombophilia without personal VTE history. […] High-risk thrombophilia without previous VTE. […] High-risk thrombophilia with one previous episode of VTE or affected first-degree relative (not receiving long-term anticoagulation therapy). […] Thrombophilia with ≥2 VTE episodes (not receiving long-term anticoagulation therapy). […] Thrombophilia with ≥2 VTE episodes (receiving long-term anticoagulation therapy). […] ACOG states “There is insufficient evidence to recommend anticoagulation as an intervention to prevent adverse pregnancy outcomes among women with inherited thrombophilias.” […] LMWH (preferred therapy) and unfractionated heparin do not cross the placenta. […] Avoid oral direct thrombin inhibitors (dabigatran) and anti-Xa inhibitors (rivaroxaban, apixaban). […] Prophylactic, intermediate or adjusted dose LMWH for 6-8 weeks as indicated.

• #28 Thrombophilias in Pregnancy Treatment & Management: Approach Considerations, Consultations, Long-Term Monitoring

  https://emedicine.medscape.com/article/2056429-treatment

  The decision to provide thromboprophylaxis to pregnant patients depends on the following: […] These factors affect the decision to provide prophylaxis, as well as the timing (antenatal or postpartum only) and intensity of therapy. Early recognition of risk factors and wide implementation of thromboprophylaxis guidelines in the UK found a significant decrease in their maternal mortality due to thromboembolisms. […] A systematic review by Croles et al reported that antepartum or postpartum thrombosis prophylaxis, or both should be considered for women with antithrombin, protein C, or protein S deficiency or with homozygous factor V Leiden. […] For patients who meet the criteria for obstetric antiphospholipid syndrome, the American College of Rheumatology (ACR) strongly recommends combined lowdose aspirin and prophylacticdose heparin (usually LMWH). The ACR strongly recommends continuing prophylacticdose anticoagulation for 6-12 weeks postpartum. […] Because data on the maternal and fetal safety of direct oral anticoagulants (DOACs) are scant, these agents are generally avoided in pregnancy.

• #29 Thrombophilia – Wikipedia

  https://en.wikipedia.org/wiki/Thrombophilia

  There is no specific treatment for most thrombophilias, but recurrent episodes of thrombosis may be an indication for long-term preventive anticoagulation. […] In those with unprovoked and/or recurrent thrombosis, or those with a high-risk form of thrombophilia, the most important decision is whether to use anticoagulation medications, such as warfarin, on a long-term basis to reduce the risk of further episodes. […] Those with antiphospholipid syndrome may be offered long-term anticoagulation after a first unprovoked episode of thrombosis. […] Women with a thrombophilia who are contemplating pregnancy or are pregnant usually require alternatives to warfarin during pregnancy, especially in the first 13 weeks, when it may produce abnormalities in the unborn child. Low molecular weight heparin (LMWH, such as enoxaparin) is generally used as an alternative. […] When women experience recurrent pregnancy loss secondary to thrombophilia, some studies have suggested that low molecular weight heparin reduces the risk of miscarriage.

• #30

  https://111.wales.nhs.uk/thrombophilia/

  Thrombophilia is a condition that increases your risk of blood clots. It’s usually treated with anticoagulant medicines. […] You do not usually need treatment for thrombophilia. You usually only need treatment if you have a blood clot, such as DVT or PE. […] The main treatment for blood clots is anticoagulant medicine. […] If you’re at high risk of blood clots, you may need to take this medicine regularly for several months or years. […] There’s an increased risk of blood clots during pregnancy with some types of thrombophilia. Speak to your GP or midwife if you’re pregnant or planning to get pregnant and you have thrombophilia.

• #31 Thrombophilia in Pregnancy: What You Need To Know

  https://www.healthline.com/health/thrombophilia-in-pregnancy

  If you are diagnosed with thrombophilia during pregnancy, a doctor may suggest you take a blood thinner to reduce the likelihood of developing a dangerous blood clot. A commonly used anticoagulant medication is low-molecular-weight heparin. […] Heparin is also given to pregnant people experiencing PE. […] If you develop signs of deep vein thrombosis or pulmonary embolism while pregnant, you should seek medical care right away. […] A doctor can help you learn more about your risk for thrombophilia in pregnancy and understand the symptoms to watch out for so you can seek medical care if needed.

• #32 Thrombophilia – Blood Clots

  https://www.stoptheclot.org/about-clots/thrombophilia/thrombophilia/

  Some individuals have an underlying vulnerability for blood clots known as thrombophilia. […] This web resource was produced specifically to help people with thrombophilia understand their condition, assess their risks in partnership with their doctor and take action to protect themselves when necessary. […] Individuals with a confirmed thrombophilia may need to take special precautions when facing surgery, planning a pregnancy, anticipating an extended period of immobilization or choosing a contraceptive method or menopause treatment. […] Sometimes blood thinners are prescribed strictly for primary clot prevention in people who have multiple risk factors, including a known thrombophilia, a strong family history of VTE, and a current health issue such as pregnancy, hospitalization or impending surgery or prolonged immobilization that are correlated with a higher incidence of clotting.

• #33 Thrombophilia: treatment | gesund.bund.de

  https://gesund.bund.de/en/thrombophilia

  In people with thrombophilia, the bodys normal formation of blood clots is disrupted. This increases the risk of potentially life-threatening blood clots, also known as thromboses. Treatment seeks to dissolve any blood clots that have already developed, or to prevent the formation of further blood clots. […] Anti-coagulant (anti-clotting) medication and medical compression stockings are normally used to treat and prevent thromboses. […] If thrombophilia has been diagnosed, physical activity and exercise are effective ways to minimize the risk of developing thromboses. […] If the risk of thrombosis is elevated in specific situations, such as after surgery or injuries, anti-clotting medication is often prescribed to prevent thromboses. […] Women with an increased risk of thrombosis who use a hormonal contraceptive pill should discuss the option of estrogen-free contraception with their gynecologist. It is now known that this type of contraception does not present a risk of thrombosis.

• #34 Factor V Leiden – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/factor-v-leiden/diagnosis-treatment/drc-20372428

  Your doctor may suspect factor V Leiden if you’ve had one or more episodes of abnormal blood clotting or if you have a strong family history of abnormal blood clots. Your doctor can confirm that you have factor V Leiden with a blood test. […] Doctors generally prescribe blood-thinning medications to treat people who develop abnormal blood clots. This type of medicine usually isn’t needed for people who have the factor V Leiden mutation but who have not experienced abnormal blood clots. […] However, your doctor might suggest that you take extra precautions to prevent blood clots if you have the factor V Leiden mutation and are going to have surgery. These precautions might include: A short course of blood thinners, Leg wraps that inflate and deflate to keep blood moving in your legs, Compression stockings, Going for walks soon after surgery.

• #35 Factor V Leiden – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/factor-v-leiden/diagnosis-treatment/drc-20372428

  If your factor V Leiden requires you to take anticoagulant medication, here are some steps that might help you prevent injury and avoid excessive bleeding: Avoid playing contact sports or engaging in other activities that could result in physical injury. Regular noncontact exercise, such as walking or swimming, is still recommended for good health. […] Does my factor V Leiden need to be treated? […] Do I need to take medication to prevent additional blood clots? […] What types of side effects can I expect from the medication?

• #36 Thrombophilia: treatment | gesund.bund.de

  https://gesund.bund.de/en/thrombophilia

  In people with thrombophilia, the bodys normal formation of blood clots is disrupted. This increases the risk of potentially life-threatening blood clots, also known as thromboses. Treatment seeks to dissolve any blood clots that have already developed, or to prevent the formation of further blood clots. […] Anti-coagulant (anti-clotting) medication and medical compression stockings are normally used to treat and prevent thromboses. […] If thrombophilia has been diagnosed, physical activity and exercise are effective ways to minimize the risk of developing thromboses. […] If the risk of thrombosis is elevated in specific situations, such as after surgery or injuries, anti-clotting medication is often prescribed to prevent thromboses. […] Women with an increased risk of thrombosis who use a hormonal contraceptive pill should discuss the option of estrogen-free contraception with their gynecologist. It is now known that this type of contraception does not present a risk of thrombosis.

• #37 What Is Thrombophilia?

  https://www.webmd.com/dvt/thrombophilia-overview

  There is no treatment for thrombophilia until you get a blood clot. What happens then depends on where the clot is, its size, and other things. […] If you have the antiphospholipid antibody syndrome form of thrombophilia, you may need long-term treatment with blood thinners. […] If you’re a woman, you may need to avoid certain forms of hormonal birth control that have estrogen. You could take progestin-only pills instead. Your doctor also may recommend staying away from hormone replacement therapy for menopause symptoms. […] If you have thrombophilia, you can lower your chances of having unwanted blood clots with lifestyle changes, including: Exercise, Keeping a healthy weight, Limiting salt, saturated fats, and cholesterol, Avoiding long periods of not moving.

• #38 What Is Thrombophilia?

  https://www.webmd.com/dvt/thrombophilia-overview

  There is no treatment for thrombophilia until you get a blood clot. What happens then depends on where the clot is, its size, and other things. […] If you have the antiphospholipid antibody syndrome form of thrombophilia, you may need long-term treatment with blood thinners. […] If you’re a woman, you may need to avoid certain forms of hormonal birth control that have estrogen. You could take progestin-only pills instead. Your doctor also may recommend staying away from hormone replacement therapy for menopause symptoms. […] If you have thrombophilia, you can lower your chances of having unwanted blood clots with lifestyle changes, including: Exercise, Keeping a healthy weight, Limiting salt, saturated fats, and cholesterol, Avoiding long periods of not moving.

• #39 Blood Clotting Disorders: Types, Signs and Treatment

  https://my.clevelandclinic.org/health/diseases/16788-blood-clotting-disorders-hypercoagulable-states

  If you’re taking warfarin, you should order and wear a medical identification bracelet so you can get proper medical care in case of an emergency situation. […] Possible ways to prevent an acquired blood clotting disorder include: Finding non-estrogen alternatives to birth control pills or hormone replacement therapy, Staying at a healthy weight, Making sure you’re getting the vitamins you need, Getting up and walking around, especially during long flights and after surgery. […] Blood clotting disorders can be genetic (inherited) or acquired. Cleveland Clinic’s experts diagnose and treat these disorders to lower your risk of complications.

• #40 Primary thrombophilia XV: antithrombotic treatment of sticky platelet syndrome worldwide – García-Navarrete – Annals of Blood

  https://aob.amegroups.org/article/view/5039/html

  Sticky platelet syndrome (SPS) is a common but under-recognized cause of thrombosis. Treatment with antiplatelet drugs results in a low re-thrombosis rate. […] Most patients with SPS are treated with antiplatelet drugs worldwide, the re-thrombosis rate is very low. Physicians worldwide are aware of the fact that the best treatment for persons with the SPS is the use of antiplatelet drugs. […] Treatment of SPS relies on diminishing the inherent platelet hyperaggregability by means of anti-platelet drugs; in most cases, aspirin appears adequate but there are situations in which other anti-platelet drugs must be employed. […] By using antiplatelet drugs, mainly aspirin, the platelet hyperreactivity of patients can be reverted and that this translates into a low re-thrombosis rate. […] The re-thrombosis rate for patients given antiplatelet drugs was 5/332 (1.5%) and only 3 patients died.

• #41 Sign up for our newsletter

  https://www.pbi.org.au/inherited-thrombophilias

  A thrombophilia is an abnormal state where the blood is more likely to clot. Genetic or inherited thrombophilia is a condition some people are born with that makes their blood more likely to clot increasing the risk of thrombosis. […] People with thrombophilia often take medication called anticoagulants, or blood-thinners, which help to reduce the risk of thrombosis. Thrombophilia patients may also be treated with factor concentrates to increase the levels of certain factors they may have deficiencies in such as Protein C or S. […] Occasionally people with thrombophilia will be given thrombolytic agents drugs that help to dissolve existing blood clots.

• #42 Thrombophilia (Hypercoagulable States) – Bleeding Disorders – Hematology – Diseases – McMaster Textbook of Internal Medicine

  https://empendium.com/mcmtextbook/chapter/B31.II.15.22.

  1. Treatment modalities and outcomes of acute VTE in patients with thrombophilia are the same as in patients with other forms of venous thrombosis. In patients with severe deficiency of natural anticoagulants, additional options (substitution) should be considered. The presence of a thrombophilia may influence the duration of treatment. […] 2. In patients who would otherwise be discontinuing anticoagulants, lifelong secondary antithrombotic prevention with a VKA or DOAC could be considered after the first episode of VTE in patients with AT deficiency, homozygotes for factor V Leiden, or patients with the 20210A variant of the prothrombin gene, as well as patients with coexisting heterozygosity for these conditions, or in patients with antiphospholipid syndrome with an unprovoked VTE event. After the first episode of unprovoked thrombosis in patients with types of thrombilia other than those mentioned above, anticoagulant treatment should be continued for 3 months. Consideration for extended-duration therapy in such patients (particularly men) is reasonable if the risk of bleeding is low to moderate. […] 3. Patients with suspected TTS should have diagnostic testing performed before treatment with high-dose IV immunoglobulins and nonheparin anticoagulants is initiated, but likely without waiting for results.

• #43 Thrombophilia | Clotting Disorders | UC Davis Hemostasis and Thrombosis Center

  https://health.ucdavis.edu/hemophilia/clotting-disorders/thrombophilia.html

  Thrombophilia is a condition in which there’s an imbalance in naturally occurring blood-clotting proteins, or clotting factors. This can put people at risk of developing blood clots. […] Treatment may not be needed at all unless a blood clot develops, or if an individual is at high risk of developing one. […] Medications may include anticoagulants such as warfarin or heparin. Warfarin (Coumadin or Jantoven) is an oral drug, but it takes a few days to start working. In the case of a clot that needs immediate treatment, heparin is a fast-acting injectable drug that can be used with the warfarin. […] Regular blood testing needs to be done to make sure that the right amount of warfarin is being taken. Blood tests include the prothrombin time test and International Normalized Ratio (INR).

• #44 Blood Clotting Disorders: Types, Signs and Treatment

  https://my.clevelandclinic.org/health/diseases/16788-blood-clotting-disorders-hypercoagulable-states

  A blood clotting disorder makes your blood form clots too easily. This is also called a hypercoagulable state or thrombophilia. […] In most cases, you only need blood clotting disorder treatment when a blood clot develops in a vein or artery. Anticoagulants decrease your blood’s ability to clot and prevent additional clots from forming. […] Anticoagulant medications include: Aspirin, Warfarin (Coumadin or Jantoven), Heparin, Low-molecular weight heparin, Fondaparinux, Direct oral anticoagulants (tablets) such as rivaroxaban, apixaban or dabigatran. […] Your healthcare provider will talk to you about the benefits and risks of these medications. This information, along with your diagnosis, will help determine the type of anticoagulant medication you will take, how long you will need to take it, and the type of follow-up monitoring you need.

• #45 Blood Clotting Disorders: Types, Signs and Treatment

  https://my.clevelandclinic.org/health/diseases/16788-blood-clotting-disorders-hypercoagulable-states

  A blood clotting disorder makes your blood form clots too easily. This is also called a hypercoagulable state or thrombophilia. […] In most cases, you only need blood clotting disorder treatment when a blood clot develops in a vein or artery. Anticoagulants decrease your blood’s ability to clot and prevent additional clots from forming. […] Anticoagulant medications include: Aspirin, Warfarin (Coumadin or Jantoven), Heparin, Low-molecular weight heparin, Fondaparinux, Direct oral anticoagulants (tablets) such as rivaroxaban, apixaban or dabigatran. […] Your healthcare provider will talk to you about the benefits and risks of these medications. This information, along with your diagnosis, will help determine the type of anticoagulant medication you will take, how long you will need to take it, and the type of follow-up monitoring you need.

• #46 Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4715840/

  Thrombophilias are hereditary and/or acquired conditions that predispose patients to thrombosis. Testing for thrombophilia is commonly performed in patients with venous thrombosis and their relatives; however such testing usually does not provide information that impacts management and may result in harm. […] We recommend that thrombophilia testing not be performed in most situations. When performed, it should be used in a highly selective manner, and only in circumstances where the information obtained will influence a decision important to the patient, and outweigh the potential risks of testing. Testing should not be performed during acute thrombosis or during the initial (3-month) period of anticoagulation. […] Testing for thrombophilias should only be performed when results will be used to improve or modify management. Testing has been suggested to assist with secondary prevention (determining the duration of anticoagulation following a thrombotic event); and for hereditary disorders, to aid in primary prevention in relatives of affected patients.

• #47 Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4715840/

  The presence of hereditary thrombophilia does not affect survival in patients with a history of VTE or the risk of post-thrombotic syndrome. […] Do not perform thrombophilia testing following an episode of provoked VTE. […] Do not perform thrombophilia testing in patients following an episode of unprovoked VTE. […] Do not test for thrombophilia in asymptomatic family members of patients with VTE or hereditary thrombophilia. […] Do not test for thrombophilia in asymptomatic family members of patients with VTE or hereditary thrombophilia who are contemplating use of estrogen. […] Do not test for thrombophilia in asymptomatic family members of patients with VTE or hereditary thrombophilia who are contemplating pregnancy. […] Do not perform thrombophilia testing at the time of VTE diagnosis or during the initial 3-month course of anticoagulant therapy.

• #48 Thrombophilia Testing and Venous Thrombosis

  https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/10/20/11/18/thrombophilia-testing-and-venous-thrombosis

  The majority of patients with venous thromboembolism (VTE) should not be tested for thrombophilia. Data supporting clinical usefulness and benefits are limited or nonexistent. […] Most patients with inherited thrombophilia can be identified by coagulation experts based on the patients personal and family history of VTE. Thrombophilia testing is usually not required. […] Do not perform thrombophilia testing at the time of a VTE event, as it can be inaccurate (often false positive). Perform testing (when indicated) after completion of initial therapy and if it might change management strategies. […] The goal of thrombophilia testing should be to aid decision making regarding future VTE prophylaxis, to guide testing of family members, and to determine the cause in severe or fatal VTE. Test results alone should not be used to decide on the duration of anticoagulation therapy.

• #49 Dissecting the Complexities of Thrombophilia Screening – Hematology Advisor

  https://www.hematologyadvisor.com/features/thrombophilia-screening-dissecting-complexities-treatment-risk/

  Investigations into the presence of inherited/acquired thrombophilia are primarily driven by the need to prevent or reduce associated morbidity and mortality. […] At this stage, evidence of thrombosis is taken as the basis for launching further investigations into possible causes in the hopes that appropriate prophylactic treatment may be administered. […] This means that thrombophilia screening, which may seem like a rational next step in all instances in which a clinician would like to rule out an identifiable etiology of thrombophilia, is potentially unnecessary or even harmful in some cases, especially when results do not meaningfully impact clinical decision making. […] Even though the debate on which clinical situations warrant screening for inherited thrombophilia remains unresolved, there is agreement that screening can be beneficial when it informs management.

• #50 Dissecting the Complexities of Thrombophilia Screening – Hematology Advisor

  https://www.hematologyadvisor.com/features/thrombophilia-screening-dissecting-complexities-treatment-risk/

  Essentially, there are only 3 potential clinical decisions that can arise from thrombophilia screening: Whether treatment for the secondary prevention of VTE should be continued or discontinued. […] Deciding if anticoagulation prophylaxis is appropriate to lower the risk of thromboembolic events. […] Whether it would be desirable to withhold hormonal treatments that may heighten the risk of VTE among women. […] Should thrombophilia screening fail to lead to one of these 3 decisions, its cost-benefit ratio then tilts heavily towards the former and it should not be performed. […] The American Society of Hematology (ASH) has issued a series of screening criteria that are both wide-ranging and stringent. […] Thrombophilia screening should also be considered in ambulatory cancer patients with a family history of VTE or are known to have low-to-intermediate risk of VTE; this allows clinicians to assess whether pharmacological thromboprophylaxis would prove helpful.

• #51 Dissecting the Complexities of Thrombophilia Screening – Hematology Advisor

  https://www.hematologyadvisor.com/features/thrombophilia-screening-dissecting-complexities-treatment-risk/

  In addition, screening is recommended in individuals with a family history of VTE or high-risk thrombophilia; the purpose of this is to assess if pharmacological thrombosis prophylaxis is necessary when transient thrombosis risk factors occur. […] These guidelines demonstrate that thrombophilia screening is most useful when it can lead to meaningful intervention that lowers the risk of thromboembolic events. […] Virtually all available guidelines are unanimous in advising against the routine ordering of coagulation factor tests to assess the risk of thrombosis. […] The BSH cautions against the blanket use of thrombophilia screening in all cases of thrombosis. […] Testing patients with VTE or relatives of patients with VTE and thrombophilia has a moderate to high chance of finding a positive test result, suggesting that the incremental value of knowing about the presence or absence of thrombophilia may be low.

• #52 Who should be tested for thrombophilia? | Genetics in Medicine

  https://www.nature.com/articles/gim920114

  No general consensus exists in the medical profession as to which patients with venous thromboembolism (VTE) and which family members should be tested for thrombophilias. […] Thrombophilia testing remains a complex issue, difficult to condense in a short clear guideline. There are two valid reasons for the clinician to consider undertaking a thrombophilia workup in a patient with unprovoked (also referred to as idiopathic or spontaneous) VTE. […] Finding a thrombophilia in this patient population does not change that recommendation, and absence or presence of inherited thrombophilia has, therefore, not been used in the 2008 American College of Chest Physician guidelines as a major factor to guide duration of anticoagulation. […] This is the patient group where finding a strong thrombophilia, i.e., one that predicts a higher risk of recurrence, may be of relevance, where continued anticoagulation becomes beneficial and acceptable, despite an increased risk of bleeding or inconvenience. These are the patients I consider for thrombophilia testing.

• #53 Guidance for the evaluation and treatment of hereditary and acquired thrombophilia

  https://pmc.ncbi.nlm.nih.gov/articles/PMC4715840/

  Thrombophilias are hereditary and/or acquired conditions that predispose patients to thrombosis. Testing for thrombophilia is commonly performed in patients with venous thrombosis and their relatives; however such testing usually does not provide information that impacts management and may result in harm. […] We recommend that thrombophilia testing not be performed in most situations. When performed, it should be used in a highly selective manner, and only in circumstances where the information obtained will influence a decision important to the patient, and outweigh the potential risks of testing. Testing should not be performed during acute thrombosis or during the initial (3-month) period of anticoagulation. […] Testing for thrombophilias should only be performed when results will be used to improve or modify management. Testing has been suggested to assist with secondary prevention (determining the duration of anticoagulation following a thrombotic event); and for hereditary disorders, to aid in primary prevention in relatives of affected patients.

• #54

  https://link.springer.com/article/10.1007/s11239-015-1316-1

  Thrombophilias are hereditary and/or acquired conditions that predispose patients to thrombosis. […] We recommend that thrombophilia testing not be performed in most situations. When performed, it should be used in a highly selective manner, and only in circumstances where the information obtained will influence a decision important to the patient, and outweigh the potential risks of testing. Testing should not be performed during acute thrombosis or during the initial (3-month) period of anticoagulation. […] Testing for thrombophilias should only be performed when results will be used to improve or modify management. […] The presence of hereditary thrombophilia does not affect survival in patients with a history of VTE or the risk of post-thrombotic syndrome. […] Thrombophilia testing is performed far more frequently than can be justified based on available evidence; the majority of such testing is not of benefit to the patient and may be harmful. Thrombophilia testing should not be performed in patients with VTE following a major provocation as extended anticoagulation is not indicated in these cases.

• #55 Hemophilia and Thrombophilia Care | Rush

  https://www.rush.edu/services/hemophilia-and-thrombophilia-care

  At Rush, you will have a multidisciplinary team of blood disorders specialists in your corner. We’ll discuss all of your treatment options with you, and we’ll tailor your care plan to the type of blood disorder you have and your specific lifestyle and needs. […] We take a holistic approach to treating blood disorders. […] Hemophilia and Thrombophilia Tests and Treatments include Anticoagulants, Blood Clotting Medications, Blood Transfusion, Cognitive Behavioral Therapy (CBT), Genetic Counseling, Genetic Testing, Nutrition Counseling, Physical Therapy, and Thrombolysis. […] Research has found that people with bleeding disorders who go to hemophilia treatment centers like the one at Rush are 40% less likely to be admitted to the hospital for bleeding complications. […] Our clinician-researchers are involved in clinical trials and research studies related to bleeding and clotting disorders. This means you will have access to new effective treatments as soon as they become available.

• #56

  https://link.springer.com/article/10.1007/s11936-008-0001-5

  Additionally, the treating physician must seek input early from a hematologist or rheumatologist when managing patients with known or suspected HIT, TTP, and myeloproliferative disorders, or the antiphospholipid syndrome, respectively. This interdisciplinary interface is critical to ensure an optimal outcome when treating patients with arterial thrombophilia.

• #57 Thrombophilia – Blood Clots

  https://www.stoptheclot.org/about-clots/thrombophilia/thrombophilia/

  People with HAD are often treated by getting extra antithrombin to compensate for the antithrombin that is missing from the body. Treatment is more common in certain high-risk situations such as surgery, pregnancy and childbirth, or when the person already has a blood clot. […] Blood clots are managed with anticoagulants, also known as blood thinners. […] The goal will be to maximize treatment benefits while minimizing adverse effects.

• #58 Thrombophilia: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/21797-thrombophilia

  Thrombophilia treatment for acquired or inherited types of the condition may include compression stockings for your legs or medicine to prevent or break up a blood clot. Some people may need surgery to remove a blood clot. […] Providers order medications, such as: Blood thinners (anticoagulants) like heparin, warfarin (Coumadin or Jantoven) or newer blood thinners like rivaroxaban or apixaban. […] Although you cant cure the kind of thrombophilia that you inherit, you can treat it. […] Its important to know that blood thinners dont dissolve blood clots. They stabilize the blood clots so they dont move or get bigger, and allow your bodys natural resources to absorb the clot over time. […] If youre at a high risk of blood clots, your provider may give you: Heparin after surgery if youre at risk for a venous thromboembolism (VTE). […] Nearly 90% of people who have thrombophilia never get a blood clot, but some people get one or more serious clots. […] You may need to take blood thinners if your risk of forming more blood clots is high.

• #59 Thrombosis (Blood Clots) | Boston Children’s Hospital

  https://www.childrenshospital.org/conditions/thrombosis

  Thrombosis is a blood clot that develops within veins or sometimes arteries in the body. Thrombosis may be serious or inconvenient but often occurs as a complication of a procedure, medication, or other disease. If left untreated a thrombosis can cause long-term problems; such as chronic swelling, pain, or even permanent damage to internal organs. […] Thrombophilia refers to a group of disorders that increases a child’s tendency to develop dangerous blood clots. There are two main types of thrombophilia: […] In most cases, thrombosis is treated with anticoagulation medications (blood thinners). These medications prevent the clot from growing and decrease the risk of its breaking apart and causing further complications. Your child may need to continue taking these medications for several months after initial treatment.

• #60 Thrombosis (Blood Clots) | Boston Children’s Hospital

  https://www.childrenshospital.org/conditions/thrombosis

  Your child’s treatment team will determine a specific care plan. Examples of anticoagulation medication your child’s physician may prescribe include: […] Other treatments may include wearing compression stockings, remaining active, and applying warm packs to improve blood flow and pain caused by the clot. […] Treatment is given to help get rid of the blood clot and to minimize complications of thrombosis. If the blood clot remains, other veins will enlarge to bypass the blockage. […] Children and young adults with blood clots are treated through the Dana-Farber/Boston Children’s Thrombosis, Anticoagulation, and Vascular Patency Program. Through our unique program, we can quickly identify children who need anticoagulation medications (or “blood-thinners”) using established monitoring and risk identification guidelines.

Zobacz więcej